Compare, Analyse Aurobindo Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
TEVA PHARMA
Dec-13
AUROBINDO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0233,080-   
Low Rs3332,676-   
Sales per share (Unadj.) Rs422.81,767.7-  
Earnings per share (Unadj.) Rs92.0110.4-  
Cash flow per share (Unadj.) Rs110.0253.3-  
Dividends per share (Unadj.) Rs4.0096.66-  
Avg Dividend yield %0.63.4 17.6%  
Book value per share (Unadj.) Rs374.31,963.5-  
Shares outstanding (eoy) m585.94848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.61.6 98.5%   
Avg P/E ratio x7.426.1 28.3%  
P/CF ratio (eoy) x6.211.4 54.3%  
Price / Book Value ratio x1.81.5 123.6%  
Dividend payout %4.387.5 5.0%   
Avg Mkt Cap Rs m397,3982,440,383 16.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m35,3500-   
Avg. sales/employee Rs ThNM33,351.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,083.4-  
INCOME DATA
Net Sales Rs m247,7461,498,970 16.5%  
Other income Rs m3,8090-   
Total revenues Rs m251,5551,498,970 16.8%   
Gross profit Rs m81,480410,494 19.8%  
Depreciation Rs m10,554121,163 8.7%   
Interest Rs m74529,442 2.5%   
Profit before tax Rs m73,990259,888 28.5%   
Minority Interest Rs m01,181 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-170,602 0.0%   
Tax Rs m20,098-3,173 -633.4%   
Profit after tax Rs m53,89293,640 57.6%  
Gross profit margin %32.927.4 120.1%  
Effective tax rate %27.2-1.2 -2,224.8%   
Net profit margin %21.86.2 348.2%  
BALANCE SHEET DATA
Current assets Rs m198,2351,012,399 19.6%   
Current liabilities Rs m106,652882,897 12.1%   
Net working cap to sales %37.08.6 427.9%  
Current ratio x1.91.1 162.1%  
Inventory Days Days1991 21.1%  
Debtors Days Days5296 53.8%  
Net fixed assets Rs m135,778489,597 27.7%   
Share capital Rs m5863,690 15.9%   
"Free" reserves Rs m218,7130-   
Net worth Rs m219,2991,665,071 13.2%   
Long term debt Rs m1,684766,457 0.2%   
Total assets Rs m334,0133,425,627 9.8%  
Interest coverage x100.39.8 1,020.9%   
Debt to equity ratio x00.5 1.7%  
Sales to assets ratio x0.70.4 169.5%   
Return on assets %16.43.6 455.3%  
Return on equity %24.65.6 437.0%  
Return on capital %33.84.9 685.8%  
Exports to sales %53.80-   
Imports to sales %16.40-   
Net fx Rs m88,3020-   
CASH FLOW
From Operations Rs m33,289238,858 13.9%  
From Investments Rs m5,987-84,637 -7.1%  
From Financial Activity Rs m-13,648-286,527 4.8%  
Net Cashflow Rs m25,831-132,305 -19.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.79 Rs / USD

Compare AUROBINDO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare AUROBINDO PHARMA With: ANUH PHARMA  IOL CHEMICALS & PHARM.  WANBURY  ZOTA HEALTH CARE  CHANDRA BHAGAT PHARMA  



Today's Market

Sensex Skyrockets 958 Points to End at New Peak; Banking & Realty Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

India's Most Trusted Corporate Group is... (Views On News)

Sep 11, 2021

We conducted a poll of 17 of the most popular corporate groups in India. With an overwhelming response from 5,274 participants, here is what we found.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


Sep 23, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

My Top 4 Sectors for 2022

Top Small Caps to Buy Now

How to Use P/E Ratio in Investing.

India's Edge in Electric Vehicle Stocks

More Featured Videos

MARKET STATS